Literature DB >> 2842261

Purification, cloning, and sequence of outer membrane protein P1 of Haemophilus influenzae type b.

R Munson1, S Grass.   

Abstract

Outer membrane protein P1 from Haemophilus influenzae type b MinnA was purified and partially characterized. Antiserum was generated against the purified protein and was used to immunologically screen a lamba EMBL3 genomic library prepared from strain MinnA DNA. A 4.2-kilobase-pair EcoRI-BamHI fragment containing the P1 gene was subcloned into pBR322. The recombinant protein was synthesized by Escherichia coli K-12, in which it localized to the outer membrane. The N-terminal sequence of the purified protein was determined and found to correspond to residues 23 through 36. The 22-amino-acid leader peptide had a typical structure, with two lysine residues near the amino terminus, a stretch of hydrophobic residues, and alanine residues at positions 20 and 22. The Mr of the processed protein was 47,752, which is in good agreement with the estimate of 50,000 from sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Putative -35 and -10 promoter sequences were identified upstream from the translational start site. Codon usage was examined and determined to be substantially different than the codon preference in E. coli.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2842261      PMCID: PMC259555          DOI: 10.1128/iai.56.9.2235-2242.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Cloning and expression in Escherichia coli of the gene encoding the heat-modifiable major outer membrane protein of Haemophilus influenzae type b.

Authors:  F R Gonzales; S Leachman; M V Norgard; J D Radolf; G H McCracken; C Evans; E J Hansen
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

2.  A minor high-molecular-weight outer membrane protein of Haemophilus influenzae type b is a protective antigen.

Authors:  A Kimura; P A Gulig; G H McCracken; T A Loftus; E J Hansen
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

3.  Sequencing DNA with dideoxyribonucleotides as chain terminators: hints and strategies for big projects.

Authors:  W M Barnes
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

4.  kappa-Bungarotoxin: complete amino acid sequence of a neuronal nicotinic receptor probe.

Authors:  G A Grant; V A Chiappinelli
Journal:  Biochemistry       Date:  1985-03-12       Impact factor: 3.162

5.  A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots.

Authors:  M S Blake; K H Johnston; G J Russell-Jones; E C Gotschlich
Journal:  Anal Biochem       Date:  1984-01       Impact factor: 3.365

6.  Outer-membrane protein subtypes of Haemophilus influenzae type b and spread of disease in day-care centers.

Authors:  S J Barenkamp; D M Granoff; R S Munson
Journal:  J Infect Dis       Date:  1981-09       Impact factor: 5.226

7.  Outer membrane protein composition in disease isolates of Haemophilus influenzae: pathogenic and epidemiological implications.

Authors:  M R Loeb; D H Smith
Journal:  Infect Immun       Date:  1980-12       Impact factor: 3.441

8.  Identification of the site of sulfation of the fourth component of human complement.

Authors:  G Hortin; H Sims; A W Strauss
Journal:  J Biol Chem       Date:  1986-02-05       Impact factor: 5.157

9.  Prospects for prevention of Haemophilus influenzae type b disease by immunization.

Authors:  D M Granoff; R S Munson
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

Review 10.  Preferential codon usage in prokaryotic genes: the optimal codon-anticodon interaction energy and the selective codon usage in efficiently expressed genes.

Authors:  H Grosjean; W Fiers
Journal:  Gene       Date:  1982-06       Impact factor: 3.688

View more
  32 in total

1.  Sequence analysis and evolutionary perspectives of ROB-1 beta-lactamase.

Authors:  J M Juteau; R C Levesque
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

2.  Novel bacterial NAD+-dependent DNA ligase inhibitors with broad-spectrum activity and antibacterial efficacy in vivo.

Authors:  Scott D Mills; Ann E Eakin; Ed T Buurman; Joseph V Newman; Ning Gao; Hoan Huynh; Kenneth D Johnson; Sushmita Lahiri; Adam B Shapiro; Grant K Walkup; Wei Yang; Suzanne S Stokes
Journal:  Antimicrob Agents Chemother       Date:  2010-12-28       Impact factor: 5.191

3.  Genomic sequence of an otitis media isolate of nontypeable Haemophilus influenzae: comparative study with H. influenzae serotype d, strain KW20.

Authors:  Alistair Harrison; David W Dyer; Allison Gillaspy; William C Ray; Rachna Mungur; Matthew B Carson; Huachun Zhong; Jenny Gipson; Mandy Gipson; Linda S Johnson; Lisa Lewis; Lauren O Bakaletz; Robert S Munson
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

4.  Cloning, expression, and sequence analysis of the Haemophilus influenzae type b strain M43p+ pilin gene.

Authors:  J R Gilsdorf; C F Marrs; K W McCrea; L J Forney
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

5.  Molecular cloning, expression, and primary sequence of outer membrane protein P2 of Haemophilus influenzae type b.

Authors:  R Munson; R W Tolan
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

6.  Comparative analysis of the structures of the outer membrane protein P1 genes from major clones of Haemophilus influenzae type b.

Authors:  R Munson; S Grass; M Einhorn; C Bailey; C Newell
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

7.  Isolation and characterization of a mutant of Haemophilus influenzae type b deficient in outer membrane protein P1.

Authors:  R Munson; A Hunt
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

8.  Cloning of the gene encoding the major outer membrane protein of Haemophilus influenzae type b.

Authors:  E J Hansen; F R Gonzales; N R Chamberlain; M V Norgard; E E Miller; L D Cope; S E Pelzel; B Gaddy; A Clausell
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

9.  Use of the riboflavin synthase gene (ribC) as a model for development of an essential gene disruption and complementation system for Haemophilus influenzae.

Authors:  Amna Saeed-Kothe; Wei Yang; Scott D Mills
Journal:  Appl Environ Microbiol       Date:  2004-07       Impact factor: 4.792

10.  Immunogenicity of synthetic peptides of Haemophilus influenzae type b outer membrane protein P1.

Authors:  P Chong; Y P Yang; D Persaud; M Haer; B Tripet; E Tam; C Sia; M Klein
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.